CTI Biotechnology (SUZHOU) CO., LTD. (hereinafter referred as CTI BIO), is a CRO company specializing in the preclinical research for new drugs, invested by Center Testing International Group Co., Ltd. CTI BIO is committed to providing pre-clinical pharmacodynamics, toxicology, pharmacokinetics and biological analysis testing services for customers of domestic and oversea biomedical enterprises and scientific research institutions.
Natural Location
CTI Biotech is located in Kunshan High-tech Zone, adjacent to Suzhou Industrial Park and Shanghai, where is the core area of Yangtze River Delta.
More
Professional Facility
The facility of phase I building covers more than 13,300 square meters with laboratories in compliance with international GLP and national standards.
More13,389m²
Experimental Lab (phase 1)
5,862m²
Conventional animal rooms
2,200m²
SPF-grade animal rooms
867m²
Auxiliary function Lab
Professional Technical Team
The core technology team consists of more than 200 people, with education background in medicine, pharmacology, toxicology, animal medicine, biology, etc.
More
Highly Educated
The core technology team consists of 6 members with senior professional titles, 4% with Doctors degree, over 60% with bachelors degree or above, 3 NMPA new drug reviewers and 2 GLP inspectors.
More
